天星医疗今日盘中大跌5.27%，引起了市场的广泛关注。
消息面上，天星医疗为近期上市新股，于5月5日登陆港交所，发行价98.5港元，香港公开发售获超高倍数认购。然而，该股未设置超额配售权（绿鞋机制）及稳价人，缺乏托底支撑，当抛压集中释放时市场只能依靠自发力量消化，这加剧了股价的波动幅度。
作为国产最大运动医学植入物及器械提供商，天星医疗上市以来筹码博弈激烈，短期波动显著，缺乏稳价机制使得股价在交易中容易出现大幅涨跌。
天星医疗今日盘中大跌5.27%，引起了市场的广泛关注。
消息面上，天星医疗为近期上市新股，于5月5日登陆港交所，发行价98.5港元，香港公开发售获超高倍数认购。然而，该股未设置超额配售权（绿鞋机制）及稳价人，缺乏托底支撑，当抛压集中释放时市场只能依靠自发力量消化，这加剧了股价的波动幅度。
作为国产最大运动医学植入物及器械提供商，天星医疗上市以来筹码博弈激烈，短期波动显著，缺乏稳价机制使得股价在交易中容易出现大幅涨跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.